Viewing Study NCT00869050


Ignite Creation Date: 2025-12-24 @ 5:19 PM
Ignite Modification Date: 2026-01-04 @ 3:57 AM
Study NCT ID: NCT00869050
Status: COMPLETED
Last Update Posted: 2016-07-25
First Post: 2009-03-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Capecitabine and Temozolomide for Neuroendocrine Cancers
Sponsor: Columbia University
Organization: